Home/Filings/4/0001562180-22-008057
4//SEC Filing

Krawtschuk Christopher 4

Accession 0001562180-22-008057

CIK 0001293971other

Filed

Dec 4, 7:00 PM ET

Accepted

Dec 5, 4:49 PM ET

Size

7.3 KB

Accession

0001562180-22-008057

Insider Transaction Report

Form 4
Period: 2022-12-01
Krawtschuk Christopher
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2022-12-01+50,00050,000 total
  • Award

    Stock Options (Right to buy)

    2022-12-01+100,000100,000 total
    Exercise: $7.61Exp: 2032-12-01Common Stock (100,000 underlying)
Footnotes (2)
  • [F1]Restricted stock unit awards vest over a four-year period at the rate of 25% on 12/1/2023, 25% on 12/1/2024, 25% on 12/1/2025, and 25% on 12/1/2026.
  • [F2]The stock option vests over a four-year period at the rate of 25% on 12/1/2023 and then in 36 equal monthly installments thereafter.

Issuer

bluebird bio, Inc.

CIK 0001293971

Entity typeother

Related Parties

1
  • filerCIK 0001952720

Filing Metadata

Form type
4
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 4:49 PM ET
Size
7.3 KB